Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype

Neuroscience Letters

Volumn 239, Issue 1, 1997, Pages 33-36

  Allen, S J ^a   MacGowan, S H ^b   Tyler, S ^a   Wilcock, G K ^b   Robertson, A G S ^a   Holden, P H ^a   Smith, S K F ^a   Dawbarn, D ^a  

^a Dept Med ^*  (United Kingdom)

^b FRENCHAY HOSPITAL   (United Kingdom)

Author keywords

Amyloid; Alzheimer's disease; Apolipoprotein E; Choline acetyltransferase

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E4; CHOLINE ACETYLTRANSFERASE;

ALLELE; ALZHEIMER DISEASE; ARTICLE; BRAIN INJURY; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DEMENTIA; GENOTYPE; HUMAN; HUMAN TISSUE; NERVE CELL PLASTICITY; PRIORITY JOURNAL; SENILE PLAQUE;

AGED; AGED, 80 AND OVER; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; BRAIN; CASE-CONTROL STUDIES; CHOLINE O-ACETYLTRANSFERASE; GENOTYPE; HIPPOCAMPUS; HUMANS; MIDDLE AGED; OCCIPITAL LOBE; REFERENCE VALUES; TEMPORAL LOBE;

EID: 0031565944     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(97)00872-0     Document Type: Article

References (20)

1. Anderson R., Higgins G.A. Absence of central cholinergic deficits in ApoE knockout mice. Psychopharmacology. 132:1997;135-144.
2. Beffert U., Poirier J. Apolipoprotein E plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann. N. Y. Acad. Sci. 777:1996;166-174.
3. Benton, J.S., Bowen, D.M., Allen, S.J., Haan, E.A., Davison, A.N., Neary, D., Murphy, R.P. and Snowden, J.S., Alzheimer's disease as a disorder of the isodendritic core, Lancet, i (1982) 456.
4. Bertrand P., Poirier J., Oda T., Finch C.E., Pasinetti G.M. Association of Apolipoprotein-E genotype with brain levels of Apolipoprotein-E and Apolipoprotein J (Clusterin) in Alzheimer disease. Mol. Brain Res. 33:1995;174-178.
5. Bowen D.M., Benton J.S., Spillane J.A., Smith C.C.T., Allen S.J. Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J. Neurol. Sci. 57:1982;191-202.
6. Bowen D.M., Smith C.B., White P., Davison A.N. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain. 99:1976;459-496.
7. Emre M., Geula C., Ransil B.J., Mesulam M.M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat-brain. Neurobiol. Aging. 13:1992;553-559.
8. Fonnum F. A rapid radiochemical method for the determination of choline acetyltransferase activity. J. Neurochem. 24:1975;407-409.
9. Gordon I., Graver E., Genis I., Schayek E., Michaelson D.M. Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199:1995;1-4.
10. Morris C.M., Massey H.M., Bejamin R., Leake A., Broadbent C., Griffiths M., Lamb H., Brown A., Ince P.G., Tyrer S., Thompson P., McKeith I.G., Edwardson J.A., Perry R.H., Perry E.K. Molecular biology of ApoE alleles in Alzheimer and non-Alzheimer dementias. J. Neural Transm. 47:1991;205-218.
11. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1457-1459.
12. Poirier J. Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17:1994;525-530.
13. Poirier J., Delisle M.C., Quirion R., Aubert I., Farlow M., Lahiri D., Hui S., Bertrand P., Nalbantoglu J., Gilfix B.M., Gauthier S. Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 92:1995;12260-12264.
14. Saunders A.M., Strittmatter W.J., Schmechel D., St George Hyslop P.H. S, Perickvance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper MacLaughlin, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D. and Roses, A.D., Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
15. Schmechel D.E., Saunders A.M., Strittmatter W.J., Crain B.J., Hulette C.M., Joo S.H., Pericakvance M.A., Goldgaber D., Roses A.D. Increased amyloid beta-peptide deposition in cerebral-cortex as a consequence of apolipoprotein-E genotype in late-onset alzheimer-disease. Proc. Natl. Acad. Sci. USA. 90:1993;9649-9653.
16. Soinenen H., Kosunen O., Helisalmi S., Mannermaa A., Paljarvi L., Talasniemi S., Ryynanen M., Riekkinen P. A severe loss of choline acetyltransferase in the frontal cortex of Alzheimer patients carrying Apolipoprotein-epsilon4 allele. Neurosci. Lett. 187:1995;79-82.
17. Strittmater W.J., Weisgraber K.H., Huang D.Y., Dong L.- M, Salvesen, G.S., Pericak-Vance, M., Schmechel, D., Saunders, A.M., Goldgaber, D. and Roses, A.D., Isoforms-specific interactions of apolipoprotein E with microtubule-associated protein tau: implication for Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 91:1994;11183-11186.
18. Wenham P.R., Price W.H., Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.
19. Wilcock G.K., Esiri M.M., Bowen D.M., Smith C.C.T. Alzheimer's disease: correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57:1982;407-417.
20. Wisniewski T., Frangione B. Apolipoprotein-E - a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.